title: MLL5 expression as a biomarker for DNA hypermethylation and sensitivity to epigenetic therapy.
authors.affiliation: MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, UK thomas.milne@imm.ox.ac.uk.
authors.forename: Thomas A
authors.initials: TA
authors.lastname: Milne
mesh_terms: D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D001374:Azacitidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004268:DNA-Binding Proteins / Q000235:genetics*; D000077209:Decitabine; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000235:genetics*; D008297:Male; D012333:RNA, Messenger / Q000235:genetics*
chemical_list: D000964:Antimetabolites, Antineoplastic; D004268:DNA-Binding Proteins; C460660:KMT2E protein, human; D012333:RNA, Messenger; D000077209:Decitabine; D001374:Azacitidine